Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why ANYONE AND I MEAN A N Y O N E

Look, I have nothing against you personally. I've enjoyed your posts in the past. We're on the same side here, I'm down over $260K on this investment right now myself. I read this forum every day also for 5 years. All of our patience has been tested here. But your not being realistic if you think that the people at the top arn't going to be overpaid for one. Also no matter how much we complain there is nothing we're going to do to change the BoD and that is reality. Do I think the BoD could be improved? Absolutely. Would I welcome change in the BoD? Absolutely. But I realize that we (you and I) arn't going to make that happen.

I would argue that the patents proved valuable early on and everything looked rosey for awhile no question about that. Management made some poor decisions and Swartz selling into every good news event didn't help much eighther. How much of those poor decisions made were due to Swatz's power and influence over PTSC at that time is a big question in my mind. But as you and I are well aware the facts show that the J's settlement and the USPTO process cast some real doubt on the strength and the value of the patents and that has proven to negatively impact TPL's ability to license companies and to get a decent price for the license. It became obvious that PTSC with it's dependence on the patents as a one trick pony would see it's SP drop and languish at the levels we are at now until the USPTO revalidation issue was resolved and the real strength of the patents are realized and the risk levels were reduced for investors. We ignored the smart money (Swartz) selling and rode this thing all the way back down. But finally we can see the end of the USPTO process for the 336 patent. When we can see how strong the 336 is and if it still has broad application, IMO investors will return because the risk is lower and new licenses will start moving the SP north not replacement of the BoD but the risk associated with patents.

I think we agree that RG is the first real CEO that PTSC has had and at least some of the decisions the company has made appear to be sound, even though we're still waiting for the PDSG end of the business to take off. What is exciting is that there is real potential for a new revenue stream and a growth in the company in a new direction for the future that was lacking when we just had the patents. I like what RG has done since he took the CEO job and it dosn't look like the current BoD has interfered with his decisions. If PTSC can hang onto this guy through this transition period when we do have some decent revenue coming in from the licensing and the PDSG business I feel confident that he will make sound decisions to grow the company into even more directions.

Eventually the good things will start outweighting the bad and as the risk level goes down the SP will rise.

And the "dim bulb" in me is growing brighter I just hope it isn't a freight train coming though the tunnel.

All the best,

Steve

Share
New Message
Please login to post a reply